Comparing Treatments in Early-Stage Pediatric Hodgkin Lymphoma
Presently, there is no well-defined standard of care for managing pediatric patients with...
Read More
chemotherapy
New Guidelines for Head & Neck Cancer Reirradiation
Recurrent and second primary head-and-neck squamous cell carcinomas (HNSCC) arising within or...
Read MoreAgent Approved for Highly Toxic Chemotherapy Levels
The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that...
Read More
The Impact of Complications on Colorectal Cancer Care
Colorectal cancer (CRC) is diagnosed in almost 150,000 patients in the United States each year and...
Read More
Updated Practice Guidelines for Ovarian Cancer
A major challenge in treating ovarian cancer is that by the time most patients are diagnosed with...
Read More
Rapid Desensitization for Chemotherapy Allergies
Chemotherapy in the 21st century is only now beginning to evolve from its early, traumatic...
Read More
Preventing Delayed CINV to Improve Patient Outcomes
Chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer...
Read More
American Society of Clinical Oncology 2010
The American Society of Clinical Oncology, or ASCO, held its 2010 annual meeting from June 4 to 8...
Read More